$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] Immunomodulatory Properties of Mesenchymal Stem Cells and Their Therapeutic Applications 원문보기

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.35 no.2, 2012년, pp.213 - 221  

Yi, TacGhee (Clinical Research Center, Inha Research Institute, Inha University School of Medicine) ,  Song, Sun U. (Clinical Research Center, Inha Research Institute, Inha University School of Medicine)

Abstract AI-Helper 아이콘AI-Helper

Mesenchymal stem cells (MSCs) are adult stem cells that can be isolated from most adult tissues, including bone marrow, adipose, liver, amniotic fluid, lung, skeletal muscle and kidney. The term MSC is currently being used to represent both mesenchymal stem cells and multipotent mesenchymal stromal ...

주제어

참고문헌 (60)

  1. Blood S. Aggarwal 105 1815 2005 10.1182/blood-2004-04-1559 Aggarwal, S., and Pittenger, M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822 (2005). 

  2. Cell Transplant. A. C. Assis 19 219 2010 10.3727/096368909X479677 Assis, A. C., Carvalho, J. L., Jacoby, B. A., Ferreira, R. L., Castanheira, P., Diniz, S. O., Cardoso, V. N., Goes, A. M., and Ferreira, A. J., Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant., 19, 219-230 (2010). 

  3. Arthritis Rheum. A. Augello 56 1175 2007 10.1002/art.22511 Augello, A., Tasso, R., Negrini, S.M., Cancedda, R., and Pennesi, G., Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum., 56, 1175-1186 (2007). 

  4. Exp. Hematol. A. Bartholomew 30 42 2002 10.1016/S0301-472X(01)00769-X Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol., 30, 42-48 (2002). 

  5. J. Immunol. M. L. Belladonna 177 130 2006 10.4049/jimmunol.177.1.130 Belladonna, M. L., Grohmann, U., Guidetti, P., Volpi, C., Bianchi, R., Fioretti, M. C., Schwarcz, R., Fallarino, F., and Puccetti, P., Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol., 177, 130-137 (2006). 

  6. Blood A. Corcione 107 367 2006 10.1182/blood-2005-07-2657 Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G. L., Pistoia, V., and Uccelli, A., Human mesenchymal stem cells modulate B-cell functions. Blood, 107, 367-372 (2006). 

  7. Blood M. Nicola Di 99 3838 2002 10.1182/blood.V99.10.3838 Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., and Gianni, A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843 (2002). 

  8. Arthritis Rheum. F. Djouad 52 1595 2005 10.1002/art.21012 Djouad, F., Fritz, V., Apparailly, F., Louis-Plence, P., Bony, C., Sany, J., Jorgensen, C., and Noel, D., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum., 52, 1595-1603 (2005). 

  9. Gut M. Duijvestein 59 1662 2010 10.1136/gut.2010.215152 Duijvestein, M., Vos, A. C., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M., Koning, F., Zwaginga, J. J., Fidder, H. H., Verhaar, A. P., Fibbe, W. E., van den Brink, G. R., and Hommes, D. W., Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut, 59, 1662-1669 (2010). 

  10. Cell Stem Cell K. English 7 431 2010 10.1016/j.stem.2010.09.009 English, K., French, A., and Wood, K. J., Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell, 7, 431-442 (2010). 

  11. Cell Tissue Kinet. A. J. Friedenstein 20 263 1987 Friedenstein, A. J., Chailakhyan, R. K., and Gerasimov, U. V., Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet., 20, 263-272 (1987). 

  12. Exp. Hematol. A. J. Friedenstein 2 83 1974 Friedenstein, A. J., Deriglasova, U. F., Kulagina, N. N., Panasuk, A. F., Rudakowa, S. F., Luria, E. A., and Ruadkow, I. A., Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol., 2, 83-92 (1974). 

  13. J. Exp. Med. G. Frumento 196 459 2002 10.1084/jem.20020121 Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., and Ferrara, G. B., Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med., 196, 459-468 (2002). 

  14. Blood S. Glennie 105 2821 2005 10.1182/blood-2004-09-3696 Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W., and Dazzi, F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821-2827 (2005). 

  15. Methods Mol. Biol. M. Gnecchi 482 281 2009 10.1007/978-1-59745-060-7_18 Gnecchi, M., and Melo, L. G., Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol. Biol., 482, 281-294 (2009). 

  16. Cytotherapy E. M. Horwitz 7 393 2005 10.1080/14653240500319234 Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., and Keating, A., Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7, 393-395 (2005). 

  17. Front. Med. R. Jiang 5 94 2011 10.1007/s11684-011-0116-z Jiang, R., Han, Z., Zhuo, G., Qu, X., Li, X., Wang, X., Shao, Y., Yang, S., and Han, Z. C., Transplantation of placentaderived mesenchymal stem cells in type 2 diabetes: a pilot study. Front. Med., 5, 94-100 (2011). 

  18. Bone C. J. Joyner 21 1 1997 10.1016/S8756-3282(97)00074-4 Joyner, C. J., Bennett, A., and Triffitt, J. T., Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone, 21, 1-6 (1997). 

  19. Gastroenterology K. H. Jung 140 998 2011 10.1053/j.gastro.2010.11.047 Jung, K. H., Song, S. U., Yi, T., Jeon, M. S., Hong, S. W., Zheng, H. M., Lee, H. S., Choi, M. J., Lee, D. H., and Hong, S. S., Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology, 140, 998-1008 (2011). 

  20. Biol. Blood Marrow Transplant. P. Kebriaei 15 804 2009 10.1016/j.bbmt.2008.03.012 Kebriaei, P., Isola, L., Bahceci, E., Holland, K., Rowley, S., McGuirk, J., Devetten, M., Jansen, J., Herzig, R., Schuster, M., Monroy, R., and Uberti, J., Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol. Blood Marrow Transplant., 15, 804-811 (2009). 

  21. J. Biomed. Sci. E. Klyushnenkova 12 47 2005 10.1007/s11373-004-8183-7 Klyushnenkova, E., Mosca, J. D., Zernetkina, V., Majumdar, M. K., Beggs, K. J., Simonetti, D. W., Deans, R. J., and McIntosh, K. R., T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci., 12, 47-57 (2005). 

  22. Stem Cells M. Krampera 24 386 2006 10.1634/stemcells.2005-0008 Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., Romagnani, P., Maggi, E., Romagnani, S., and Annunziato, F., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 24, 386-398 (2006). 

  23. Lancet K. Blanc Le 371 1579 2008 10.1016/S0140-6736(08)60690-X Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., Dini, G., Egeler, R. M., Bacigalupo, A., Fibbe, W., and Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: a phase II study. Lancet, 371, 1579-1586 (2008). 

  24. Lancet K. Blanc Le 363 1439 2004 10.1016/S0140-6736(04)16104-7 Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363, 1439-1441 (2004). 

  25. Scand. J. Immunol. K. Blanc Le 57 11 2003 10.1046/j.1365-3083.2003.01176.x Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S. E., and Ringden, O., Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol., 57, 11-20 (2003a). 

  26. Exp. Hematol. K. Blanc Le 31 890 2003 10.1016/S0301-472X(03)00110-3 Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringden, O., HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol., 31, 890-896 (2003b). 

  27. Int. J. Hematol. J. H. Lim 92 204 2010 10.1007/s12185-010-0606-9 Lim, J. H., Lee, M. H., Yi, H. G., Kim, C. S., Kim, J. H., and Song, S. U., Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases. Int. J. Hematol., 92, 204-207 (2010). 

  28. Haematologica R. Maccario 90 516 2005 Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Ibatici, A., Piaggio, G., Pozzi, S., Frassoni, F., and Locatelli, F., Interaction of human mesenchymal stem cells with cells involved in alloantigen- specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica, 90, 516-525 (2005). 

  29. Bone Marrow Transplant. B. Maitra 33 597 2004 10.1038/sj.bmt.1704400 Maitra, B., Szekely, E., Gjini, K., Laughlin, M. J., Dennis, J., Haynesworth, S. E., and Koc, O. N., Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant., 33, 597-604 (2004). 

  30. Blood R. Meisel 103 4619 2004 10.1182/blood-2003-11-3909 Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., and Dilloo, D., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation. Blood, 103, 4619-4621 (2004). 

  31. Discov. Med. R. H. Miller 9 236 2010 Miller, R. H., Bai, L., Lennon, D. P., and Caplan, A. I., The potential of mesenchymal stem cells for neural repair. Discov. Med., 9, 236-242 (2010). 

  32. Mills, C. R., Osiris therapeutics announces preliminary results for prochymal phase III GVHD trials. ( http://investor.osiris.com/releasedetail.dfm?releaseID=407404 ) (2009). 

  33. Science D. H. Munn 297 1867 2002 10.1126/science.1073514 Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., Slingluff, C. L., Jr., and Mellor, A. L., Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science, 297, 1867-1870 (2002). 

  34. J. Immunol. A. J. Nauta 177 2080 2006 10.4049/jimmunol.177.4.2080 Nauta, A. J., Kruisselbrink, A. B., Lurvink, E., Willemze, R., and Fibbe, W. E., Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocytederived dendritic cells. J. Immunol., 177, 2080-2087 (2006). 

  35. Proc. Natl. Acad. Sci. U. S. A. L. A. Ortiz 100 8407 2003 10.1073/pnas.1432929100 Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., and Phinney, D. G., Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U. S. A., 100, 8407-8411 (2003). 

  36. Science M. F. Pittenger 284 143 1999 10.1126/science.284.5411.143 Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R., Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147 (1999). 

  37. J. Immunol. A. Poggi 175 6352 2005 10.4049/jimmunol.175.10.6352 Poggi, A., Prevosto, C., Massaro, A. M., Negrini, S., Urbani, S., Pierri, I., Saccardi, R., Gobbi, M., and Zocchi, M. R., Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J. Immunol., 175, 6352-6360 (2005). 

  38. Science D. J. Prockop 276 71 1997 10.1126/science.276.5309.71 Prockop, D. J., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71-74 (1997). 

  39. J. Cell. Mol. Med. D. J. Prockop 14 2190 2010 10.1111/j.1582-4934.2010.01151.x Prockop, D. J., Kota, D. J., Bazhanov, N., and Reger, R. L., Evolving paradigms for repair of tissues by adult stem/ progenitor cells (MSCs). J. Cell. Mol. Med., 14, 2190-2199 (2010). 

  40. Int. J. Mol. Med. H. Qian 22 325 2008 Qian, H., Yang, H., Xu, W., Yan, Y., Chen, Q., Zhu, W., Cao, H., Yin, Q., Zhou, H., Mao, F., and Chen, Y., Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int. J. Mol. Med., 22, 325-332 (2008). 

  41. Transplantation R. Ramasamy 83 71 2007 10.1097/01.tp.0000244572.24780.54 Ramasamy, R., Fazekasova, H., Lam, E. W., Soeiro, I., Lombardi, G., and Dazzi, F., Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 83, 71-76 (2007). 

  42. Transplantation I. Rasmusson 76 1208 2003 10.1097/01.TP.0000082540.43730.80 Rasmusson, I., Ringden, O., Sundberg, B., and Le Blanc, K., Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76, 1208-1213 (2003). 

  43. Expert Opin. Biol. Ther. J. Reiser 5 1571 2005 10.1517/14712598.5.12.1571 Reiser, J., Zhang, X. Y., Hemenway, C. S., Mondal, D., Pradhan, L., and La Russa, V. F., Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin. Biol. Ther., 5, 1571-1584 (2005). 

  44. Cell Stem Cell G. Ren 2 141 2008 10.1016/j.stem.2007.11.014 Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., and Shi, Y., Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2, 141-150 (2008). 

  45. Transplantation O. Ringden 81 1390 2006 10.1097/01.tp.0000214462.63943.14 Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H. U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., and Le Blanc, K., Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81, 1390-1397 (2006). 

  46. N. Engl. J. Med. A. Rosenzweig 355 1274 2006 10.1056/NEJMe068172 Rosenzweig, A., Cardiac cell therapy-mixed results from mixed cells. N. Engl. J. Med., 355, 1274-1277 (2006). 

  47. E. K. Sage 2008 The Role of Bone Marrow-derived Stem Cells in Lung Regeneration and Repair Sage, E. K., Loebinger, M. R., Polak, J., and Janes, S. M., The Role of Bone Marrow-derived Stem Cells in Lung Regeneration and Repair. StemBook, Harvard Stem Cell Institute, Cambridge, (2008). 

  48. E. Schipani 2008 Adult Mesenchymal Stem Cells Schipani, E., and Kornberg, H. M., Adult Mesenchymal Stem Cells. StemBook, Harvard Stem Cell Institute, Cambridge, (2008). 

  49. Stem Cells Dev. S. U. Song 17 451 2008 10.1089/scd.2007.0167 Song, S. U., Kim, C. S., Yoon, S. P., Kim, S. K., Lee, M. H., Kang, J. S., Choi, G. S., Moon, S. H., Choi, M. S., Cho, Y. K., and Son, B. K., Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion. Stem Cells Dev., 17, 451-461 (2008). 

  50. Stem Cells P. A. Sotiropoulou 24 74 2006 10.1634/stemcells.2004-0359 Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., and Papamichail, M., Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 24, 74-85 (2006). 

  51. Endocr. Dev. A. Spagnoli 9 17 2005 10.1159/000085719 Spagnoli, A., Longobardi, L., and O’Rear, L., Cartilage disorders: potential therapeutic use of mesenchymal stem cells. Endocr. Dev., 9, 17-30 (2005). 

  52. Tissue Eng. Part A H. Tian 16 1769 2010 10.1089/ten.tea.2009.0625 Tian, H., Bharadwaj, S., Liu, Y., Ma, P. X., Atala, A., and Zhang, Y., Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng. Part A, 16, 1769-1779 (2010). 

  53. Stem Cells J. Tolar 28 1446 2010 10.1002/stem.459 Tolar, J., Le Blanc, K., Keating, A., and Blazar, B. R., Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells, 28, 1446-1455 (2010). 

  54. Transplantation W. T. Tse 75 389 2003 10.1097/01.TP.0000045055.63901.A9 Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., and Guinan, E. C., Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75, 389-397 (2003). 

  55. Nat. Rev. Immunol. A. Uccelli 8 726 2008 10.1038/nri2395 Uccelli, A., Moretta, L., and Pistoia, V., Mesenchymal stem cells in health and disease. Nat. Rev. Immunol., 8, 726-736 (2008). 

  56. Blood E. K. Waller 85 2422 1995 10.1182/blood.V85.9.2422.bloodjournal8592422 Waller, E. K., Olweus, J., Lund-Johansen, F., Huang, S., Nguyen, M., Guo, G. R., and Terstappen, L., The “common stem cell” hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood, 85, 2422-2435 (1995). 

  57. J. Neuroimmunol. B. Yamout 227 185 2010 10.1016/j.jneuroim.2010.07.013 Yamout, B., Hourani, R., Salti, H., Barada, W., El-Hajj, T., Al-Kutoubi, A., Herlopian, A., Baz, E. K., Mahfouz, R., Khalil-Hamdan, R., Kreidieh, N. M., El-Sabban, M., and Bazarbachi, A., Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J. Neuroimmunol., 227, 185-189 (2010). 

  58. Blood E. Zappia 106 1755 2005 10.1182/blood-2005-04-1496 Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., Mancardi, G., and Uccelli, A., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106, 1755-1761 (2005). 

  59. World J. Gastroenterol. D. C. Zhao 11 3431 2005 10.3748/wjg.v11.i22.3431 Zhao, D. C., Lei, J. X., Chen, R., Yu, W.H., Zhang, X. M., Li, S. N., and Xiang, P., Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J. Gastroenterol., 11, 3431-3440 (2005). 

  60. Blood R. Zohar 90 3471 1997 10.1182/blood.V90.9.3471 Zohar, R., Sodek, J., and McCulloch, C. A., Characterization of stromal progenitor cells enriched by flow cytometry. Blood, 90, 3471-3481 (1997). 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로